Quoin Pharmaceuticals reports 4 of 6 patients improved in NS compassionate use trial
Go back to Quoin Pharmaceuticals reports 4 of 6 patients improved in NS compassionate use trial| (NASDAQ: QNRX) | Delayed: 4.57 -0.08 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.65 | 52 Week High | $ | |||
| Open | $4.56 | 52 Week Low | $ | |||
| Day High | $4.83 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $ | |||
| Volume | 14,425 | |||||

